Roche Holding AG (OTCMKTS:RHHVF – Get Free Report)’s stock price rose 0.1% during trading on Tuesday . The stock traded as high as $439.7740 and last traded at $439.7740. Approximately 2,214 shares were traded during trading, a decline of 68% from the average daily volume of 7,026 shares. The stock had previously closed at $439.16.
Roche Stock Performance
The business has a 50 day simple moving average of $402.04 and a 200-day simple moving average of $356.14.
About Roche
Roche Holding AG, traded on the OTCMKTS under the symbol RHHVF, is a leading global healthcare company with two core business divisions: Pharmaceuticals and Diagnostics. The company focuses on developing innovative medicines and diagnostic tests that address serious diseases, driving advances in personalized healthcare and precision medicine.
In its Pharmaceuticals division, Roche pioneers targeted therapies across oncology, immunology, ophthalmology and neuroscience. Flagship products include monoclonal antibodies and small-molecule treatments such as Herceptin, Avastin and Actemra, which have become standards of care for cancer and autoimmune conditions.
Featured Stories
- Five stocks we like better than Roche
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- A U.S. “birthright” claim worth trillions – activated quietly
- Executive Order 14330: Trump’s Biggest Yet
Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.
